Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


More On

Justices rule for drug makers in vaccine dispute

The Supreme Court ruled for drug manufacturers Tuesday, deciding that a case brought by a Pennsylvania family who says their child was injured by a vaccine cannot be heard outside of a court created to hear such claims.

The Bruesewitz family engaged in what they called a "fight for justice," claiming that a combined disease-prevention booster shot left their then-infant daughter with severe physical injuries. But the justices, by a 6-2 vote, concluded that drug makers cannot be sued outside a special judicial forum set up by Congress in 1986 to address specific claims over safety.

The so-called "vaccine court," which has handled such disputes, was designed to ensure a reliable, steady supply of vaccines by reducing the threat of expensive lawsuits against pharmaceutical firms.

Read the complete CNN story, "Justices rule for drug makers in vaccine dispute."

Join the Conversation

Advertisement. Closing in 15 seconds.